| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |